Maggi Roberto, Menozzi Carlo, Brignole Michele, Podoleanu Cristian, Iori Matteo, Sutton Richard, Moya Angel, Giada Franco, Orazi Serafino, Grovale Nicoletta
Department of Cardiology, Arrhythmologic Centre, Ospedali del Tigullio, Via don Bobbio 24, 16033 Lavagna, Italy.
Europace. 2007 Aug;9(8):563-7. doi: 10.1093/europace/eum092. Epub 2007 May 16.
We correlated the finding of cardioinhibitory carotid sinus hypersensitivity (CSH) with that observed during a spontaneous syncopal relapse by means of an implantable loop recorder (ILR).
We included 18 consecutive patients with suspected recurrent neurally mediated syncope and positive cardioinhibitory response during carotid sinus massage (max pause 5.5 +/- 1.6 s) who had subsequent documentation of a spontaneous syncope by means of an ILR. They were compared with a 2:1 age- and sex-matched group of 36 patients with a clinical diagnosis of recurrent neurally mediated syncope and negative response to carotid sinus massage, tilt testing and ATP test. Asystole >3 s was observed at the time of the spontaneous syncope in 16 (89%) of CSH patients and in 18 (50%) of the control group (P = 0.007). Sinus arrest was the most frequent finding among CSH patients but not among controls (72 vs. 28%, P = 0.003). After ILR documentation, 14 CSH patients with asystole received dual-chamber pacemaker implantation; during 35 +/- 22 months of follow-up, 2 syncopal episodes recurred in 2 patients (14%), and pre-syncope occurred in another 2 patients (14%). Syncope burden decreased from 1.68 (95% confidence interval 1.66 - 1.70) episodes per patient per year before to 0.04 (0.038-0.042) after pacemaker implant (98% relative risk reduction).
In patients with suspected neurally mediated syncope, the finding of cardioinhibitory CSH predicts an asystolic mechanism at the time of spontaneous syncope and, consequently, suggests a possible benefit of cardiac pacing therapy.
我们通过植入式循环记录仪(ILR),将心脏抑制性颈动脉窦过敏(CSH)的检查结果与在自发性晕厥复发期间观察到的结果进行关联。
我们纳入了18例连续的疑似复发性神经介导性晕厥且在颈动脉窦按摩期间有心脏抑制性反应阳性(最大停顿时间5.5±1.6秒)的患者,这些患者随后通过ILR记录到了自发性晕厥。将他们与一个年龄和性别匹配的对照组进行比较,该对照组有36例临床诊断为复发性神经介导性晕厥且对颈动脉窦按摩、倾斜试验和ATP试验反应阴性的患者。在自发性晕厥时,16例(89%)CSH患者出现了>3秒的心脏停搏,而对照组中有18例(50%)出现了心脏停搏(P = 0.007)。窦性停搏在CSH患者中是最常见的发现,但在对照组中并非如此(72%对28%,P = 0.003)。在ILR记录后,14例出现心脏停搏的CSH患者接受了双腔起搏器植入;在35±22个月的随访期间,2例患者出现了2次晕厥复发(14%),另外2例患者出现了先兆晕厥(14%)。晕厥负担从起搏器植入前每位患者每年1.68次(95%置信区间1.66 - 1.70)发作降至植入后0.04次(0.038 - 0.042)发作(相对风险降低98%)。
在疑似神经介导性晕厥的患者中,心脏抑制性CSH的检查结果预示着自发性晕厥时的心脏停搏机制,因此提示心脏起搏治疗可能有益。